Johnson & Johnson COVID-19 vaccine

A number of 60,000 doses of Janssen (Johnson & Johnson) COVID-19 vaccine will arrive on Thursday at the Cantacuzino National Institute for Medical-Military Research and Development in Bucharest, the National COVID-19 Vaccination Coordination Committee (CNCAV) informs.

The U.S. Food and Drug Administration said on June 11 it had told Johnson & Johnson that millions of doses of Covid vaccine produced at a troubled plant can't be used because of possible contamination issues.

Romania's National COVID-19 Vaccination Coordination Committee (CNCAV) has reported that in the last 24 hours, 41,554 doses of vaccine were administered, of which 28,383 doses of the Pfizer vaccine, 2,648 of the Moderna vaccine, 1,413 of the AstraZeneca vaccine and 9,110 of the Johnson & Johnson vaccine.

Experts consider the symptoms to be inked to the vaccine

Turkey has so far administered more than 20 million coronavirus vaccine jabs across the country, the Health Ministry data showed on April 19. 

More than 12.2 million people to date have received their first doses, while second doses have been given to over 7.79 million, according to the data.

Bulgarian Health Minister Kostadin Angelov announced this week that the country's roll-out of the AstraZeneca vaccine may be discontinued due to lack of interest.

Recently between 100 and 200 doses per day of the AstraZeneca vaccine have been administered throughout the country.

The European Union said on April 14 that it is expecting 50 million Pfizer coronavirus vaccine doses earlier than expected, as the United States said it would continue a pause in vaccinations using the Johnson & Johnson shot for at least another week so regulators can assess possible blood clot links.

Denmark becomes the first country that has ceased giving the Oxford-AstraZeneca vaccine amid concerns about rare cases of blood clots, the first country to do so entirely.

The move is expected to delay the country's vaccination programme by several weeks.

European Union, US and South Africa and  will temporarily stop the rollout of the Johnson & Johnson (J&J) Covid jab, after reports of rare blood clotting.

Six cases were detected in more than 6.8 million doses of the vaccine, the US Food and Drug Administration (FDA) said.

Johnson & Johnson has paused its EU rollout, which started this week.

U.S. health authorities have recommended pausing the Johnson & Johnson COVID-19 shot over blood clot fears, with the company announcing it would delay its European rollout in a setback for global immunization efforts.